Sun Pharma receives warning letter from USFDA for Halol facility

17 Dec 2022 Evaluate

Sun Pharmaceutical Industries has received Warning Letter from United States Food and Drug Administration (USFDA) for the Halol facility. The Warning Letter summarizes violations with respect to Current Good Manufacturing Practice (cGMP) regulations. USFDA shall make public the contents of the Warning Letter in due course.

Earlier, the USFDA had placed the company’s Halol facility under 'import alert'. The USFDA had conducted a GMP inspection of the company’s Halol facility (Gujarat, India) from April 26 to May 9, 2022.

Sun Pharmaceutical Industries is the world's fourth largest specialty generic pharmaceutical company and India's top pharmaceutical company.

Sun Pharma Inds. Share Price

1786.05 -40.05 (-2.19%)
10-Jan-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1786.05
Dr. Reddys Lab 1354.20
Cipla 1470.05
Lupin 2190.50
Zydus Lifesciences 1004.05
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.